Back
Top 0.2%
24.1%
Top 0.2%
12.8%
Top 33%
7.0%
Top 70%
7.0%
Top 0.3%
7.0%
Top 15%
7.0%
Top 15%
3.0%
Top 2%
3.0%
Top 2%
2.1%
Top 3%
2.1%
Top 0.4%
1.7%
Top 0.7%
1.7%
Top 3%
1.3%
Top 0.4%
1.2%
Top 15%
1.0%
Top 1%
1.0%
Top 9%
1.0%
Top 22%
1.0%
Top 10%
1.0%
Top 7%
0.8%
Top 7%
0.5%
Top 8%
0.5%
Top 70%
0.5%
NGFR as a biomarker and actionable target in cisplatin-based chemoradiotherapy-resistant HNSCC
2025-12-29
oncology
Title + abstract only
View on medRxiv
Show abstract
Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy with high mortality rates, often exhibiting resistance to conventional treatments such as radiotherapy (RT) or a combination of chemotherapy and radiotherapy (CRT). The nerve growth factor receptor (NGFR, also known as p75NTR or CD271) is a well-established cancer stem cell marker in melanoma, where it has been linked to resistance to multiple therapies. In HNSCC, NGFR has been reported as a poor prognostic marker, with it...
Predicted journal destinations
1
Cancers
57 training papers
2
Frontiers in Oncology
34 training papers
3
Scientific Reports
701 training papers
4
PLOS ONE
1737 training papers
5
Clinical Cancer Research
22 training papers
6
Nature Communications
483 training papers
7
eLife
262 training papers
8
Cancer Medicine
17 training papers
9
BMC Cancer
21 training papers
10
British Journal of Cancer
22 training papers
11
Aging
18 training papers
12
Communications Biology
36 training papers
13
International Journal of Molecular Sciences
39 training papers
14
EBioMedicine
21 training papers
15
Proceedings of the National Academy of Sciences
100 training papers
16
Cell Reports
25 training papers
17
iScience
74 training papers
18
JAMA Network Open
125 training papers
19
Frontiers in Immunology
140 training papers
20
PeerJ
46 training papers
21
Journal of Clinical Investigation
50 training papers
22
Diagnostics
36 training papers
23
BMJ Open
553 training papers